Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.8 USD | -4.17% | -7.31% | -21.84% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Bearish |
Resistance | 26.22 | 32.80 | 32.66 |
Spread/Res. | -9.12% | -27.35% | -27.04% |
Spread/Supp. | +3.61% | +19.03% | +14.79% |
Support | 23.00 | 20.02 | 20.76 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.